Study supports need for more control over prescribed drugs for youths

by Jared Wadley
U-M research supports need for more control over prescribed drugs for youths
A young woman in consultation with a consultant or psychologist

(Medical Xpress)—Teens who are prescribed pain relievers, such as Vicodin and OxyContin, are at "notable risk" for abusing opioid drugs, says a University of Michigan researcher.

Carol Boyd, U-M professor of nursing and women's studies and a research scientist at the U-M Addiction Research Center, says there are many reasons why adolescents misuse opioid —including increased tolerance to the medication, which can lead to continued use of the drug after the initial prescription is finished.

"There is evidence that once an adolescent has been medically exposed to a potentially addictive medication, adolescents are more likely to engage in nonmedical use and diversion, including buying, selling and giving away pills," said Boyd, who will present the data this week at the Association for Medical Education and Research in Substance Abuse conference.

The Food and Drug Administration recently proposed a tightening of its rules regarding hydrocodone formulations (e.g., Vicodin), recommending that these opioid medications should have stricter controls in place like OxyContin.

During the conference, Boyd will receive the 2013 Betty Ford Award for her significant impact on the field of alcohol and drug abuse, particularly with regards to women's issues, education and recovery.

Boyd has been committed to reducing among adolescents, dedicating the past 10 years to studying the misuse and abuse of controlled medications by youth and young adults.

With funding from the National Institute on Drug Abuse, Boyd and her team recently sampled more than 2,600 Michigan students who completed a web-based survey about substance use, behavior disorders and pain symptoms.

About 70 percent reported they never used painkillers; 24.5 percent were classified as medical opioid users (those who used their medications as prescribed); 3.5 percent were described as nonmedical self-treaters (those who used someone else's opioids for pain); and 1.6 percent were called nonmedical sensation-seekers.

Adolescents in this latter group get high, experiment or create altered states with someone else's medications, while those with medical clearance used their own . It is the nonmedical sensation-seekers that Boyd believes are at greatest risk for drug-related problems.

However, all teens in the study who use prescribed opioids had substance use and behavioral disorders that, while not as severe as nonmedical sensation seekers, were significantly higher than youth who had never received a prescription for an opioid painkiller.

When factoring in gender differences among medical users, girls with opioid prescriptions were at greater risk for some behavioral problems that were different from their male counterparts.

Boyd says the findings suggest, among other things, that a motive behind the use of narcotic painkillers may be more relevant than the means of obtaining the medication when considering adolescents' prescription .

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

1 hour ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a drug from AbbVie while pulling back on those from rival drugmakers.

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.